Search by Drug Name or NDC
NDC 62559-0376-30 Fesoterodine Fumarate 8 mg/1 Details
Fesoterodine Fumarate 8 mg/1
Fesoterodine Fumarate is a ORAL TABLET, FILM COATED, EXTENDED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by ANI Pharmaceuticals, Inc.. The primary component is FESOTERODINE FUMARATE.
Product Information
| NDC | 62559-0376 |
|---|---|
| Product ID | 62559-376_31d5e1bf-b31b-4f4b-96ab-11a164a890ec |
| Associated GPIs | |
| GCN Sequence Number | 064001 |
| GCN Sequence Number Description | fesoterodine fumarate TAB ER 24H 8 MG ORAL |
| HIC3 | R1A |
| HIC3 Description | URINARY TRACT ANTISPASMODIC/ANTIINCONTINENCE AGENT |
| GCN | 99712 |
| HICL Sequence Number | 035606 |
| HICL Sequence Number Description | FESOTERODINE FUMARATE |
| Brand/Generic | Generic |
| Proprietary Name | Fesoterodine Fumarate |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Fesoterodine Fumarate |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET, FILM COATED, EXTENDED RELEASE |
| Route | ORAL |
| Active Ingredient Strength | 8 |
| Active Ingredient Units | mg/1 |
| Substance Name | FESOTERODINE FUMARATE |
| Labeler Name | ANI Pharmaceuticals, Inc. |
| Pharmaceutical Class | n/a |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA204504 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 62559-0376-30 (62559037630)
| NDC Package Code | 62559-376-30 |
|---|---|
| Billing NDC | 62559037630 |
| Package | 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (62559-376-30) |
| Marketing Start Date | 2023-01-04 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 0.98971 |
| Pricing Unit | EA |
| Effective Date | 2024-02-21 |
| NDC Description | FESOTERODINE ER 8 MG TABLET |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 1 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis